Effect of Low Molecular Weight Heparin on Survival of Stage I, II or IIIA Non Small Cell Lung Cancer. A Multicenter, Open, Randomized Controlled Trial.
Phase of Trial: Phase III
Latest Information Update: 27 Sep 2018
At a glance
- Drugs Tinzaparin sodium (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Acronyms TILT
- 27 Sep 2018 Results published in the European Respiratory Journal.
- 15 Sep 2016 Last checked against ClinicalTrials.gov record.
- 01 Sep 2016 Status changed from active, no longer recruiting to completed.